Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Salil Goorha"'
Autor:
Amanda Lipsitt, Lisa Beattie, Elaine Harstead, Ying Li, Salil Goorha, Gabriela Maron, Stephen Gottschalk, Brandon Triplett, Swati Naik
Publikováno v:
Pediatric Blood & Cancer. 70
Autor:
Amanda, Lipsitt, Lisa, Beattie, Elaine, Harstead, Ying, Li, Salil, Goorha, Gabriela, Maron, Stephen, Gottschalk, Brandon, Triplett, Swati, Naik
Publikováno v:
Pediatric bloodcancerREFERENCES.
Hematological toxicity (hematotoxicity) leading to peripheral cytopenias is a common long-term adverse effect following the use of CD19-chimeric antigen receptor (CD19-CAR) T-cell therapies. However, management remains unclear for patients whose cyto
Autor:
Amanda Lipsitt, Lisa Beattie, Elaine Harstead, Ying Li, Salil Goorha, Gabriela Maron, Stephen Gottschalk, Brandon Triplett, Swati Naik
Hematological toxicity (hematotoxicity) is the most common long-term adverse effect following the use of CD19-chimeric antigen receptor (CD19-CAR) T-cell therapies. However, its management remains unclear. We present the case of a 21-year-old who rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::577f8ff1f345a4c9cd0a0b978544bba3
https://doi.org/10.22541/au.166315142.27403264/v1
https://doi.org/10.22541/au.166315142.27403264/v1
Autor:
Morgan Walker, George E. Nelson, Athena L V Hobbs, Salil Goorha, Nicholas A Turner, Christina T. Fiske, Priyenka Thapa, Ronald M Beaulieu, Steven S Spires, Jeffrey Wright, John W. Gnann, Muhammad Sheikh, Imad Omer, Ryan K Dare
Publikováno v:
Infection Control and Hospital Epidemiology
Objective:Identify risk factors that could increase progression to severe disease and mortality in hospitalized SARS-CoV-2 patients in the Southeast region of the United States.Design, setting, and participants:Multicenter, retrospective cohort inclu
Publikováno v:
Journal of Clinical Oncology. 40:e18586-e18586
e18586 Background: Recommendations for clinical trial consideration are ubiquitous across all cancers. However, it is challenging to identify patients from underrepresented communities and offer them opportunities to enroll in clinical trials due to
Autor:
Salil Goorha, Nathan D. Seligson, Elizabeth L Mills, Joanna M Leonard, Athena L V Hobbs, Amy G Evans
Publikováno v:
Annals of Pharmacotherapy. 52:439-445
Background: Treatment for acute myeloid leukemia (AML) has remained relatively unchanged over the past few decades. Although recent drug approvals have provided an increase in the number of treatment options in AML, further optimization of standard i
Fulminant soft-tissue extension of anaplastic multiple myeloma masquerading as postoperative abscess
Publikováno v:
Current Orthopaedic Practice. 25:589-591
Autor:
Kristen M. Shannon, Carolyn Farrell, Tuya Pal, Gwen Reiser, Heather Hampel, Elizabeth M. Swisher, P. Kelly Marcom, Allison W. Kurian, Robert Pilarski, Virginia Kaklamani, Jeffrey N. Weitzel, Saundra S. Buys, Jennifer K. Litton, Stephen B. Gruber, Kenneth Offit, Wendy Kohlmann, Salil Goorha, Jeffrey R. Smith, Judy Garber, Susan Friedman, Robert L. Nussbaum, Beth Crawford, Mary B. Daly, Jennifer E. Axilbund, Boris Pasche
Publikováno v:
Journal of the National Comprehensive Cancer Network. 8:562-594
Autor:
Jinghui Zhang, Masami Ishii, Salil Goorha, Guangchun Song, Xueyuan Cao, Susana C. Raimondi, Charles G. Mullighan, Jinjun Cheng, Ina Radtke, Ramapriya Ganti, Jing Ma, Sheila A. Shurtleff, James R. Downing, Xiaoping Su, Jianling Armstrong, Raul C. Ribeiro, Stanley Pounds, Zhongling Cai, Caroline Obert, Jeffrey E. Rubnitz
Publikováno v:
Proceedings of the National Academy of Sciences. 106:12944-12949
Pediatric de novo acute myeloid leukemia (AML) is an aggressive malignancy with current therapy resulting in cure rates of only 60%. To better understand the cause of the marked heterogeneity in therapeutic response and to identify new prognostic mar
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 19(2)
To compare the response to different insulin regimens for management of hyperglycemia in diabetic patients with hematologic malignancies who are receiving dexamethasone.A retrospective analysis was conducted to determine whether a basal bolus insulin